{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-002702","form_type":"8-K","ticker":"VYGR","cik":"0001640266","company_name":"Voyager Therapeutics, Inc.","filed_at":"2025-03-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.273309+00:00","generated_at":"2026-05-24T23:45:17.016059+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Voyager Therapeutics Q4 2024 net loss $34.5M; tau gene therapy VY1706 IND filing planned for 2026","bullets":["Net loss $34.5M in Q4 2024 vs net income $56.4M in Q4 2023; full year net loss $65.0M vs income $132.3M.","Collaboration revenue $6.3M in Q4 2024 vs $90.1M in Q4 2023; $80.0M full year vs $250.0M in 2023.","Cash and marketable securities $332.4M as of Dec 31, 2024; runway extended into mid-2027 excluding milestones.","Tau silencing gene therapy VY1706 reduced tau mRNA 50-73% in NHP study; IND filing anticipated in 2026.","Anti-tau antibody VY7523 MAD study initiated; initial tau PET data in Alzheimer's patients expected H2 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-002702","json":"https://secwatch.observer/filing/0001558370-25-002702.json","markdown":"https://secwatch.observer/filing/0001558370-25-002702.md","text":"https://secwatch.observer/filing/0001558370-25-002702.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1640266/000155837025002702/0001558370-25-002702-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1640266/000155837025002702/vygr-20250311x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T23:45:17.016059+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}